Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.63
+0.05 (0.76%)
Mar 20, 2026, 1:32 PM EDT - Market open
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $421.03 million as of March 20, 2026. Its market cap has increased by 12.53% in one year.
Market Cap
421.03M
Enterprise Value
265.17M
1-Year Change
12.53%
Ranking
Category
Stock Price
$6.63
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has increased from $397.73M to $421.03M, an increase of 5.86%. That is a compound annual growth rate of 1.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 417.85M | 20.73% |
| Dec 31, 2025 | 346.09M | -15.71% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | 397.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aclaris Therapeutics | 441.38M |
| Neumora Therapeutics | 441.12M |
| 4D Molecular Therapeutics | 437.00M |
| Assembly Biosciences | 435.29M |
| Shattuck Labs | 432.25M |
| Absci | 430.06M |
| REGENXBIO | 427.36M |
| Invivyd | 426.72M |